BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37977144)

  • 21. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
    Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
    Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9.
    Wattanapanitch M
    Methods Mol Biol; 2021; 2211():193-211. PubMed ID: 33336279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of Monoclonal iPSC Lines with Stable Cas9 Expression and High Cas9 Activity.
    Liao JQ; Zhou G; Zhou Y
    Methods Mol Biol; 2022; 2454():575-588. PubMed ID: 32567018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
    Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
    Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
    Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
    Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation.
    Rodriguez-Polo I; Mißbach S; Petkov S; Mattern F; Maierhofer A; Grządzielewska I; Tereshchenko Y; Urrutia-Cabrera D; Haaf T; Dressel R; Bartels I; Behr R
    Sci Rep; 2021 Jul; 11(1):15439. PubMed ID: 34326359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling.
    Arias-Fuenzalida J; Jarazo J; Qing X; Walter J; Gomez-Giro G; Nickels SL; Zaehres H; Schöler HR; Schwamborn JC
    Stem Cell Reports; 2017 Nov; 9(5):1423-1431. PubMed ID: 28988985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
    Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
    Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
    Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient and allele-specific genome editing of disease loci in human iPSCs.
    Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
    Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells.
    Wen W; Cheng X; Fu Y; Meng F; Zhang JP; Zhang L; Li XL; Yang Z; Xu J; Zhang F; Botimer GD; Yuan W; Sun C; Cheng T; Zhang XB
    Stem Cell Reports; 2018 Jun; 10(6):1821-1834. PubMed ID: 29754960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.
    Martin RM; Ikeda K; Cromer MK; Uchida N; Nishimura T; Romano R; Tong AJ; Lemgart VT; Camarena J; Pavel-Dinu M; Sindhu C; Wiebking V; Vaidyanathan S; Dever DP; Bak RO; Laustsen A; Lesch BJ; Jakobsen MR; Sebastiano V; Nakauchi H; Porteus MH
    Cell Stem Cell; 2019 May; 24(5):821-828.e5. PubMed ID: 31051134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR Base Editing in Induced Pluripotent Stem Cells.
    Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
    Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CGMP Compliant Microfluidic Transfection of Induced Pluripotent Stem Cells for CRISPR-Mediated Genome Editing.
    Bohrer LR; Stone NE; Wright AT; Han S; Sicher I; Sulchek TA; Mullins RF; Tucker BA
    Stem Cells; 2023 Nov; 41(11):1037-1046. PubMed ID: 37632456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.